重要性是模型對已發布報導給出的 1–5 分，不是對市場的預測。
已排定事件列上的影響是公司顯著度層級（高/中由圖譜中心度與規模判定；低僅用於人工整理的次要事件），不是對波動幅度的預測。
標記為已確認的財報日期，是 Yahoo Finance 認定由公司確認的；預估表示尚未公布。未加標記的列沒有可查的出處記錄。
經濟數據發布屬於總體經濟、不歸屬任何產業，因此在任何檢視下都會保留。沒有數值的發布表示尚未公布，頁面會直說，而不是顯示為零。
涵蓋被追蹤公司的即將到來的事件；已過去的事件會歸檔，並在可得時補上結果——這些結果都經人工整理並附引用，絕不杜撰。沒有結果的歷史列會顯示「結果待定」。
閉鎖期屆滿或指數調整的列會多出一行算術——將變得可賣出的股數，或指數基金必須買進的股數，以佔流通股的比例表示——依招股說明書或指數編製方法讀出，兩個數字都在該列註明出處。它陳述的是機制，不是價格走勢。由 IPO + 180 天推算出的閉鎖期日期會一直標為預估，直到公司自己說明為止。
10月12日週一 · 今天
10月13日週二
7月30日週四
財報
Madrigal Pharmaceuticals reported "Second-quarter 2026 Rezdiffra (resmetirom) net sales of $364.3 million, representing year-over-year growth of 71%." Management noted Rezdiffra "has already achieved nearly $1.3 billion in trailing-12-month net sales."
大盤 開啟原文 ↗
7月29日週三
7月28日週二
財報
Enphase Energy reported "quarterly revenue of $291.9 million in the second quarter of 2026," with "GAAP gross margin of 60.0%" and "non-GAAP gross margin of 46.8%."
大盤 開啟原文 ↗
7月27日週一
7月24日週五
合作
GE Aerospace said it and CFM International, "a 50/50 company of GE Aerospace and Safran Aircraft Engines, announced commitments for ~1,800 engines" at the Farnborough Airshow. Announcements included an IndiGo memorandum of understanding for more than 1,000 LEAP-1A engines to power 510 Airbus A320neo Family aircraft, described as the largest single order ever placed for LEAP engines, Philippine Airlines selecting GEnx-1B engines for 15 Boeing 787-10 aircraft, and "AerCap's selection of GEnx-1B engines to power 15 additional Boeing 787 Dreamliners."
Accessibility: Skip TopNav GE Aerospace Wraps Historic Farnborough Airshow Commitment for ~1,800 engines*, including largest LEAP agreement ever with IndiGo July 24, 2026 08:53 ET | Source: GE Aerospace GE Aerospace FARNBOROUGH, England, July 24, 2026 (GLOBE NEWSWIRE) -- GE Aerospace (NYSE: GE) wrapped up the 2026 Farnborough International Airshow with record engine demand, continued momentum across durability and services, and major advances in hybrid electric flight. H. Lawrence Culp, Jr., Chairman and CEO of GE Aerospace, said, “At GE Aerospace, we are focused on delivering for our customer…
大盤 開啟原文 ↗
監管
Sanofi announced it will not submit amlitelimab in atopic dermatitis for global regulatory reviews.
大盤 開啟原文 ↗
7月23日週四
財報
RTX reported adjusted sales of $24.7 billion, up 16% organically, with adjusted earnings per share up 21% to $1.89 and adjusted segment operating profit up 18% to $3.2 billion. Operating cash flow was $3.5 billion and free cash flow $2.9 billion, with backlog of $289 billion ($170 billion commercial, $119 billion defense). The company raised its full-year outlook.
大盤 開啟原文 ↗
